rs11603538

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_031471.6(FERMT3):​c.787-10C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.346 in 1,573,828 control chromosomes in the GnomAD database, including 95,407 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.33 ( 8621 hom., cov: 33)
Exomes 𝑓: 0.35 ( 86786 hom. )

Consequence

FERMT3
NM_031471.6 intron

Scores

2
Splicing: ADA: 0.00009313
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -3.52

Publications

11 publications found
Variant links:
Genes affected
FERMT3 (HGNC:23151): (FERM domain containing kindlin 3) Kindlins are a small family of proteins that mediate protein-protein interactions involved in integrin activation and thereby have a role in cell adhesion, migration, differentiation, and proliferation. The protein encoded by this gene has a key role in the regulation of hemostasis and thrombosis. This protein may also help maintain the membrane skeleton of erythrocytes. Mutations in this gene cause the autosomal recessive leukocyte adhesion deficiency syndrome-III (LAD-III). Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jan 2010]
FERMT3 Gene-Disease associations (from GenCC):
  • leukocyte adhesion deficiency 3
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 11-64219241-C-A is Benign according to our data. Variant chr11-64219241-C-A is described in ClinVar as Benign. ClinVar VariationId is 402862.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.39 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_031471.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FERMT3
NM_031471.6
MANE Select
c.787-10C>A
intron
N/ANP_113659.3
FERMT3
NM_001382362.1
c.787-10C>A
intron
N/ANP_001369291.1
FERMT3
NM_178443.3
c.787-10C>A
intron
N/ANP_848537.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FERMT3
ENST00000345728.10
TSL:1 MANE Select
c.787-10C>A
intron
N/AENSP00000339950.5
FERMT3
ENST00000279227.10
TSL:1
c.787-10C>A
intron
N/AENSP00000279227.5
FERMT3
ENST00000698865.1
c.798C>Ap.Pro266Pro
synonymous
Exon 7 of 15ENSP00000513992.1

Frequencies

GnomAD3 genomes
AF:
0.333
AC:
50641
AN:
151968
Hom.:
8605
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.307
Gnomad AMI
AF:
0.296
Gnomad AMR
AF:
0.398
Gnomad ASJ
AF:
0.262
Gnomad EAS
AF:
0.292
Gnomad SAS
AF:
0.278
Gnomad FIN
AF:
0.296
Gnomad MID
AF:
0.242
Gnomad NFE
AF:
0.352
Gnomad OTH
AF:
0.334
GnomAD2 exomes
AF:
0.328
AC:
61757
AN:
188526
AF XY:
0.324
show subpopulations
Gnomad AFR exome
AF:
0.303
Gnomad AMR exome
AF:
0.404
Gnomad ASJ exome
AF:
0.262
Gnomad EAS exome
AF:
0.279
Gnomad FIN exome
AF:
0.301
Gnomad NFE exome
AF:
0.343
Gnomad OTH exome
AF:
0.330
GnomAD4 exome
AF:
0.348
AC:
494079
AN:
1421740
Hom.:
86786
Cov.:
36
AF XY:
0.345
AC XY:
242592
AN XY:
703964
show subpopulations
African (AFR)
AF:
0.307
AC:
9900
AN:
32244
American (AMR)
AF:
0.410
AC:
15837
AN:
38650
Ashkenazi Jewish (ASJ)
AF:
0.260
AC:
6628
AN:
25464
East Asian (EAS)
AF:
0.315
AC:
11637
AN:
36914
South Asian (SAS)
AF:
0.273
AC:
22158
AN:
81306
European-Finnish (FIN)
AF:
0.304
AC:
15267
AN:
50144
Middle Eastern (MID)
AF:
0.266
AC:
1520
AN:
5720
European-Non Finnish (NFE)
AF:
0.358
AC:
390962
AN:
1092390
Other (OTH)
AF:
0.342
AC:
20170
AN:
58908
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
17559
35117
52676
70234
87793
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12612
25224
37836
50448
63060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.333
AC:
50694
AN:
152088
Hom.:
8621
Cov.:
33
AF XY:
0.331
AC XY:
24621
AN XY:
74334
show subpopulations
African (AFR)
AF:
0.307
AC:
12731
AN:
41506
American (AMR)
AF:
0.398
AC:
6090
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.262
AC:
910
AN:
3470
East Asian (EAS)
AF:
0.291
AC:
1501
AN:
5152
South Asian (SAS)
AF:
0.278
AC:
1341
AN:
4826
European-Finnish (FIN)
AF:
0.296
AC:
3126
AN:
10568
Middle Eastern (MID)
AF:
0.250
AC:
73
AN:
292
European-Non Finnish (NFE)
AF:
0.352
AC:
23939
AN:
67970
Other (OTH)
AF:
0.339
AC:
714
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1777
3553
5330
7106
8883
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
512
1024
1536
2048
2560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.332
Hom.:
3338
Bravo
AF:
0.340
Asia WGS
AF:
0.336
AC:
1166
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Nov 11, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency

Leukocyte adhesion deficiency 3 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.011
DANN
Benign
0.61
PhyloP100
-3.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000093
dbscSNV1_RF
Benign
0.034
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11603538; hg19: chr11-63986713; COSMIC: COSV107232884; COSMIC: COSV107232884; API